| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 1 | -156 | 100% | $1.88 | -$293 |
| Net | -1 | -156 | -100% | -$293 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Peter Virsik | Chief Operating Officer | $46.9K | Oct 7, 2024 | ||
| Scott Requadt | Director | $0 | Oct 9, 2025 | ||
| Marella Thorell | Director | $0 | Oct 9, 2025 | ||
| David S. Wood | Chief Financial Officer | $0 | Oct 9, 2025 | ||
| Richard Glickman | Director | $0 | Oct 9, 2025 | ||
| John Alexander Martin | Director | $0 | Oct 9, 2025 | ||
| Biotech Growth N V | 10%+ Owner | $0 | Nov 1, 2024 | ||
| David Parkinson | President and CEO, Director | $0 | Oct 9, 2025 | ||
| Franklin Berger | Director | $0 | Oct 9, 2025 | ||
| Bvf Partners L P/Il | 10%+ Owner | $0 | -$293 | -100% | Oct 9, 2025 |
| Lauren Merendino | Director | Mar 25, 2024 | |||
| Gary Sollis | Director | Mar 25, 2024 | |||
| Alessandra Cesano | Chief Medical Officer | Mar 25, 2024 | |||
| Sanford Zweifach | Director | Mar 25, 2024 | |||
| Philip W. Kantoff | Director | Mar 25, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|